Search research articles
Contact Us
Filters
Showing results (251-260 of 329) with videos related to
Page
of 33
Sort By:
Scientific Reports
|
June 10, 2022
Identification of bronchoalveolar and blood immune-inflammatory biomarker signature associated with poor 28-day outcome in critically ill COVID-19 patients
Guillaume Voiriot, Karim Dorgham, Guillaume Bachelot, et al.
ERJ Open Research
|
February 17, 2018
Real-life experience of ceritinib in crizotinib-pretreated <i>ALK</i><sup>+</sup> advanced non-small cell lung cancer patients
Jacques Cadranel, Alexis B Cortot, Hervé Lena, et al.
ERJ Open Research
|
February 3, 2021
The DIAMORFOSIS (DIAgnosis and Management Of lung canceR and FibrOSIS) survey: international survey and call for consensus
Argyris Tzouvelekis, Katerina Antoniou, Michael Kreuter, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
April 30, 2026
Integrative and interactive genomic analyses guiding personalized combined therapy improve clinical benefit in metastatic patients: A monocentric real-life experience
Jelena Filipovic, Emma Anjorand, Laetitia Marisa, et al.
Respirology (Carlton, Vic.)
|
March 18, 2024
Chronic interstitial lung disease associated with systemic lupus erythematosus: A multicentric study of 89 cases
Lou Deneuville, Arthur Mageau, Marie Pierre Debray, et al.
The European Respiratory Journal
|
September 19, 2015
Erlotinib versus carboplatin and paclitaxel in advanced lepidic adenocarcinoma: IFCT-0504
Jacques Cadranel, Radj Gervais, Patrick Merle, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 13, 2019
High MET Overexpression Does Not Predict the presence of MET exon 14 Splice Mutations in NSCLC: Results From the IFCT PREDICT.amm study
Simon Baldacci, Martin Figeac, Martine Antoine, et al.
Lung Cancer (Amsterdam, Netherlands)
|
October 3, 2025
Real-world efficacy and safety of amivantamab in EGFR exon-20-mutant non-small cell lung cancer in a French early-access program: Amexon 20 GFPC study
Thomas Pierret, Laurent Greillier, Florian Guisier, et al.
Lung Cancer (Amsterdam, Netherlands)
|
May 21, 2021
Circulating tumor DNA in advanced non-small-cell lung cancer patients with HIV is associated with shorter overall survival: Results from a Phase II trial (IFCT-1001 CHIVA)
Marie Wislez, Charlotte Domblides, Laurent Greillier, et al.
The Oncologist
|
August 28, 2020
Therapeutic Potential of Afatinib in NRG1 Fusion-Driven Solid Tumors: A Case Series
Jacques Cadranel, Stephen V Liu, Michaël Duruisseaux, et al.
Page
of 33
Search research articles
Search
Showing results (251-260 of 329) with videos related to
Sort By:
Page
of 33
Scientific Reports
|
June 10, 2022
Identification of bronchoalveolar and blood immune-inflammatory biomarker signature associated with poor 28-day outcome in critically ill COVID-19 patients
Guillaume Voiriot, Karim Dorgham, Guillaume Bachelot, et al.
ERJ Open Research
|
February 17, 2018
Real-life experience of ceritinib in crizotinib-pretreated <i>ALK</i><sup>+</sup> advanced non-small cell lung cancer patients
Jacques Cadranel, Alexis B Cortot, Hervé Lena, et al.
ERJ Open Research
|
February 3, 2021
The DIAMORFOSIS (DIAgnosis and Management Of lung canceR and FibrOSIS) survey: international survey and call for consensus
Argyris Tzouvelekis, Katerina Antoniou, Michael Kreuter, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
April 30, 2026
Integrative and interactive genomic analyses guiding personalized combined therapy improve clinical benefit in metastatic patients: A monocentric real-life experience
Jelena Filipovic, Emma Anjorand, Laetitia Marisa, et al.
Respirology (Carlton, Vic.)
|
March 18, 2024
Chronic interstitial lung disease associated with systemic lupus erythematosus: A multicentric study of 89 cases
Lou Deneuville, Arthur Mageau, Marie Pierre Debray, et al.
The European Respiratory Journal
|
September 19, 2015
Erlotinib versus carboplatin and paclitaxel in advanced lepidic adenocarcinoma: IFCT-0504
Jacques Cadranel, Radj Gervais, Patrick Merle, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 13, 2019
High MET Overexpression Does Not Predict the presence of MET exon 14 Splice Mutations in NSCLC: Results From the IFCT PREDICT.amm study
Simon Baldacci, Martin Figeac, Martine Antoine, et al.
Lung Cancer (Amsterdam, Netherlands)
|
October 3, 2025
Real-world efficacy and safety of amivantamab in EGFR exon-20-mutant non-small cell lung cancer in a French early-access program: Amexon 20 GFPC study
Thomas Pierret, Laurent Greillier, Florian Guisier, et al.
Lung Cancer (Amsterdam, Netherlands)
|
May 21, 2021
Circulating tumor DNA in advanced non-small-cell lung cancer patients with HIV is associated with shorter overall survival: Results from a Phase II trial (IFCT-1001 CHIVA)
Marie Wislez, Charlotte Domblides, Laurent Greillier, et al.
The Oncologist
|
August 28, 2020
Therapeutic Potential of Afatinib in NRG1 Fusion-Driven Solid Tumors: A Case Series
Jacques Cadranel, Stephen V Liu, Michaël Duruisseaux, et al.
Page
of 33